Although multiple linear regression-based limited sampling strategies (LSS) have been published for enteric-coated mycophenolate sodium (EC-MS), none have been evaluated for the prediction of subsequent mycophenolic acid (MPA) exposure. This study aimed to examine the predictive performance of the published LSS for the estimation of future MPA area under the concentration-time curve from 0 to 12 hours (AUC0-12) in renal transplant recipients.Total MPA plasma concentrations were measured in twenty adult renal transplant patients on two occasions a week apart. All subjects received concomitant tacrolimus and were approximately one-month post transplant. Samples were taken at 0, 0.33, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, and 8 hours and 0, 0.25,...
used in organ transplantation to prevent acute rejection. Because MMF can produce hematologic and/or...
The delayed release of mycophenolic acid (MPA) from enteric-coated mycophenolate sodium (EC-MPS, myf...
Objectives: Although monitoring of cyclosporin (CsA) is standard clinical practice postrenal transpl...
Multiple limited sampling strategies (LSSs) have been proposed for estimation of mycophenolic acid (...
Background. Enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil (MMF) are prodrug...
Previous studies predicted that limited sampling strategies (LSS) for estimation of mycophenolic aci...
Previous studies predicted that limited sampling strategies (LSS) for estimation of mycophenolic aci...
Background: Individualization of mycophenolate mofetil (MMF) dosing based on mycophenolic acid (MPA)...
Mycophenolate mofetil, the oral prodrug of mycophenolic acid, is indicated as immunosuppressive ther...
Background Therapeutic drug monitoring of mycophenolic acid (MPA) is usually performed with a limite...
Objective: The pharmacokinetics of mycophenolic acid (MPA) were compared in renal transplant patient...
Abstract Background The optimal dose of mycophenolate mofetil (MMF) in renal transplant patients has...
BACKGROUND AND OBJECTIVE: Mycophenolate mofetil is a prodrug of mycophenolic acid (MPA), an immunosu...
Background. Three randomized-controlled trials have examined the utility of mycophenolic acid (MPA) ...
Mycophenolate mofetil (MMF) is increasingly used for the treatment of autoimmune diseases (AID). In ...
used in organ transplantation to prevent acute rejection. Because MMF can produce hematologic and/or...
The delayed release of mycophenolic acid (MPA) from enteric-coated mycophenolate sodium (EC-MPS, myf...
Objectives: Although monitoring of cyclosporin (CsA) is standard clinical practice postrenal transpl...
Multiple limited sampling strategies (LSSs) have been proposed for estimation of mycophenolic acid (...
Background. Enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil (MMF) are prodrug...
Previous studies predicted that limited sampling strategies (LSS) for estimation of mycophenolic aci...
Previous studies predicted that limited sampling strategies (LSS) for estimation of mycophenolic aci...
Background: Individualization of mycophenolate mofetil (MMF) dosing based on mycophenolic acid (MPA)...
Mycophenolate mofetil, the oral prodrug of mycophenolic acid, is indicated as immunosuppressive ther...
Background Therapeutic drug monitoring of mycophenolic acid (MPA) is usually performed with a limite...
Objective: The pharmacokinetics of mycophenolic acid (MPA) were compared in renal transplant patient...
Abstract Background The optimal dose of mycophenolate mofetil (MMF) in renal transplant patients has...
BACKGROUND AND OBJECTIVE: Mycophenolate mofetil is a prodrug of mycophenolic acid (MPA), an immunosu...
Background. Three randomized-controlled trials have examined the utility of mycophenolic acid (MPA) ...
Mycophenolate mofetil (MMF) is increasingly used for the treatment of autoimmune diseases (AID). In ...
used in organ transplantation to prevent acute rejection. Because MMF can produce hematologic and/or...
The delayed release of mycophenolic acid (MPA) from enteric-coated mycophenolate sodium (EC-MPS, myf...
Objectives: Although monitoring of cyclosporin (CsA) is standard clinical practice postrenal transpl...